NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,276,227 | +1.1% | 81,251 | +0.2% | 1.76% | +8.2% |
Q2 2023 | $8,185,920 | +9.2% | 81,121 | -0.4% | 1.63% | +5.1% |
Q1 2023 | $7,496,712 | +9.5% | 81,486 | +8.0% | 1.55% | +9.5% |
Q4 2022 | $6,847,546 | +20.8% | 75,480 | +1.2% | 1.42% | +11.3% |
Q3 2022 | $5,669,000 | -9.0% | 74,579 | +1.2% | 1.27% | -3.0% |
Q2 2022 | $6,228,000 | -1.3% | 73,680 | +2.4% | 1.31% | +7.3% |
Q1 2022 | $6,313,000 | +4.1% | 71,946 | +3.7% | 1.22% | +7.7% |
Q4 2021 | $6,067,000 | +11.4% | 69,358 | +4.2% | 1.14% | +2.7% |
Q3 2021 | $5,444,000 | -2.9% | 66,566 | +8.4% | 1.10% | -10.7% |
Q2 2021 | $5,604,000 | +13.3% | 61,425 | +6.2% | 1.24% | +1.9% |
Q1 2021 | $4,946,000 | +0.1% | 57,861 | +10.5% | 1.21% | -12.4% |
Q4 2020 | $4,943,000 | +18.3% | 52,343 | +8.9% | 1.39% | -3.5% |
Q3 2020 | $4,180,000 | -0.9% | 48,069 | -0.5% | 1.44% | -6.1% |
Q2 2020 | $4,219,000 | +1672.7% | 48,302 | +1574.8% | 1.53% | +527.5% |
Q1 2020 | $238,000 | – | 2,884 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |